Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > NEVER SEEN BEFORE
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by cashflow98on May 06, 2016 12:31pm
95 Views
Post# 24848416

RE:NEVER SEEN BEFORE

RE:NEVER SEEN BEFORE
fdfd12 wrote:
This type of analysis for a company.
How much did they raise prices? For which drugs they raised?
Is there a decline in volumes?

How amy % declines in volumes compared to price increases?

DOES ANYONE GO AND DO THIS TO MERCK  PFEIZER OR JNJ?


Here's one reason why. Merck, Pfizer, JNJ all in the top 10, VRX spent $260K, Concordia spent $130,000. Makes you wonder about bias in Congressional hearings. https://www.opensecrets.org/lobby/indusclient.php?id=H04&year=2015
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested